KalshiTech & Science
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
COMP360 Psilocybin for Treatment-Resistant Depression
Current odds
-1.0 pts · 24h (leader)Before Jan 1, 202734%
No66%
COMP360 Psilocybin for Treatment-Resistant Depression